In newly reported clinical trial results, The Wistar Institute and Stanford University have successfully tested an investigational drug for the treatment of Epstein-Barr Virus (EBV)-positive nasophar…
PHILADELPHIA — (December 20th, 2024) — In its annual Excellence Index, Newsweek and the Best Practice Institute has recognized The Wistar Institute as one of the world’s top 1000 companies. Wistar le…
PHILADELPHIA — (December 10, 2024) — The Wistar Institute assistant professors Nan Zhang, Ph.D., and Noam Auslander Ph.D., have both received independent funding totaling $1.2 million over the next t…
PHILADELPHIA — (December 3rd, 2024) — The Wistar Institute’s David B. Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distingu…
PHILADELPHIA — (Nov. 27, 2024) — Governor Josh Shapiro’s Administration, through the Commonwealth of Pennsylvania Redevelopment Assistance Capital Program (RACP), has granted The Wistar Institute $2…
PHILADELPHIA — (Nov. 26, 2024) — The Wistar Institute’s Alessandro Gardini, Ph.D., and lab have shed new light on how certain biological processes determine the development of neural cells. Their fin…
PHILADELPHIA — (November 21, 2024) — The Wistar Institute’s Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center’s Molecular and Cellular Oncogenesis Program, and lab ha…
PHILADELPHIA — (November 19, 2024) — A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in…
PHILADELPHIA — (NOV. 14, 2024) — The Wistar Institute’s Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive weekl…
PHILADELPHIA — (October 11, 2024) — In the latest issue of The Philadelphia Business Journal, The Wistar Institute’s Maureen Murphy, Ph.D. — Deputy Director of the Ellen and Ronald Caplan Cancer Cent…
